78 results
Page 4 of 4
8-K
EX-99.1
70z93
7 Nov 19
Arcturus Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
4:53pm
8-K
EX-99.1
43a54aof1a8hhqqxpz5
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
424B5
hf82n7dq3zyv
27 Sep 19
Prospectus supplement for primary offering
4:14pm
8-K
EX-99.1
7j5jonjb7vnsc8vx8r8
15 Aug 19
Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update
8:09am
8-K
EX-99.1
y4e9m6
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
424B5
6kf lgbb4f
5 Aug 19
Prospectus supplement for primary offering
9:08am
8-K
EX-99.1
ovg1 srgu3cqar1
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
424B5
89uaipa
2 Aug 19
Prospectus supplement for primary offering
4:28pm
8-K
pqtwdvvt2f7
29 Jul 19
Entry into a Material Definitive Agreement
4:05pm
S-3
i7ryn7pt
21 Jun 19
Shelf registration
5:29pm
8-K
EX-10.2
ij68mq73w
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
8-K12B
EX-14.1
zkqwz 1q6o
14 Jun 19
Notification of registration of securities
5:10pm
424B3
4hzsw08fhlkzzd9vs0i
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
m659kbvv0pmivk a9v
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
szw9yo 5vnlh
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm